loading
Newamsterdam Pharma Company Nv stock is traded at $25.00, with a volume of 638.47K. It is up +2.29% in the last 24 hours and up +9.03% over the past month. NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
See More
Previous Close:
$24.44
Open:
$24.61
24h Volume:
638.47K
Relative Volume:
0.78
Market Cap:
$2.82B
Revenue:
$14.09M
Net Income/Loss:
$-176.94M
P/E Ratio:
-11.63
EPS:
-2.15
Net Cash Flow:
$-141.24M
1W Performance:
-0.28%
1M Performance:
+9.03%
6M Performance:
+34.63%
1Y Performance:
+51.24%
1-Day Range:
Value
$24.35
$25.65
1-Week Range:
Value
$23.68
$25.90
52-Week Range:
Value
$14.06
$27.29

Newamsterdam Pharma Company Nv Stock (NAMS) Company Profile

Name
Name
Newamsterdam Pharma Company Nv
Name
Phone
35 206 2971
Name
Address
GOOIMEER 2-35, NARRDEN
Name
Employee
77
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
NAMS's Discussions on Twitter

Compare NAMS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
NAMS
Newamsterdam Pharma Company Nv
25.00 2.86B 14.09M -176.94M -141.24M -2.15
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Newamsterdam Pharma Company Nv Stock (NAMS) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-17-25 Initiated Goldman Neutral
Jun-17-25 Initiated Citigroup Buy
Jun-10-25 Initiated Stifel Buy
Jun-04-25 Initiated Cantor Fitzgerald Overweight
Dec-30-24 Initiated H.C. Wainwright Buy
May-15-24 Initiated TD Cowen Buy
Mar-14-24 Initiated Scotiabank Sector Outperform
Jan-18-24 Initiated Guggenheim Buy
Jan-16-24 Initiated Piper Sandler Overweight
Oct-30-23 Initiated RBC Capital Mkts Outperform
View All

Newamsterdam Pharma Company Nv Stock (NAMS) Latest News

pulisher
Aug 20, 2025

Published on: 2025-08-20 15:56:49 - beatles.ru

Aug 20, 2025
pulisher
Aug 19, 2025

NewAmsterdam announces acceptance of MAA for review by EMA for obicetrapib - MSN

Aug 19, 2025
pulisher
Aug 19, 2025

NewAmsterdam Pharma Company N.V. (NAMS) Reports Q2 Loss, Tops Revenue Estimates - MSN

Aug 19, 2025
pulisher
Aug 18, 2025

Rainbows and Unicorns: NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Analysts Just Became A Lot More Optimistic - simplywall.st

Aug 18, 2025
pulisher
Aug 18, 2025

NewAmsterdam Announces Acceptance of Marketing Authorization Applications f - TradeVenue

Aug 18, 2025
pulisher
Aug 18, 2025

Nov Inc. shares rise 1.36% intraday after NewAmsterdam Pharma Company N.V. announced regulatory submissions for obicetrapib. - AInvest

Aug 18, 2025
pulisher
Aug 18, 2025

NewAmsterdam Announces Acceptance of Marketing - GlobeNewswire

Aug 18, 2025
pulisher
Aug 18, 2025

40% LDL Reduction: NewAmsterdam's Novel Oral Cholesterol Drug Could Help Millions Missing Treatment Goals - Stock Titan

Aug 18, 2025
pulisher
Aug 18, 2025

Chart overlay techniques for tracking NewAmsterdam Pharma Company N.V.2025 Year in Review & Reliable Volume Spike Trade Alerts - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

How to integrate NewAmsterdam Pharma Company N.V. Equity Warrant into portfolio analysis toolsGap Up & Smart Allocation Stock Tips - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Is this a good reentry point in NewAmsterdam Pharma Company N.V. Equity Warrant2025 Performance Recap & Free Technical Confirmation Trade Alerts - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

News impact scoring models applied to NewAmsterdam Pharma Company N.V2025 Major Catalysts & Verified High Yield Trade Plans - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Using Python tools to backtest NewAmsterdam Pharma Company N.V. strategies2025 Market Trends & Community Consensus Stock Picks - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

News impact scoring models applied to NewAmsterdam Pharma Company N.V.Weekly Trade Review & Daily Oversold Stock Bounce Ideas - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Visual analytics tools that track NewAmsterdam Pharma Company N.V. performancePortfolio Update Summary & Advanced Swing Trade Entry Plans - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Can NewAmsterdam Pharma Company N.V. recover in the next quarterEarnings Risk Report & Risk Managed Investment Entry Signals - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Heatmap analysis for NewAmsterdam Pharma Company N.V. Equity Warrant and competitorsIPO Watch & Risk Controlled Swing Alerts - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Price action breakdown for NewAmsterdam Pharma Company N.V.Wall Street Watch & Intraday High Probability Alerts - Newser

Aug 18, 2025
pulisher
Aug 17, 2025

Can NewAmsterdam Pharma Company N.V. Equity Warrant recover in the next quarterEarnings Growth Summary & Weekly Chart Analysis and Guides - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Will NewAmsterdam Pharma Company N.V. Equity Warrant benefit from macro trends - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Does NewAmsterdam Pharma Company N.V. Equity Warrant fit your quant trading model2025 Price Action Summary & Risk Adjusted Buy/Sell Alerts - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

How to use Fibonacci retracement on NewAmsterdam Pharma Company N.V. Equity WarrantPortfolio Return Report & Long-Term Safe Investment Ideas - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

NewAmsterdam Pharma Company N.V. Equity Warrant’s volatility index tracking explainedEarnings Risk Report & Consistent Profit Focused Trading Strategies - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Applying chart zones and confluence areas to NewAmsterdam Pharma Company N.V.2025 Sector Review & High Yield Stock Recommendations - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Is NewAmsterdam Pharma Company N.V. trending in predictive chart models2025 Investor Takeaways & Daily Stock Trend Watchlist - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Can momentum traders help lift NewAmsterdam Pharma Company N.V.2025 Price Action Summary & AI Driven Price Predictions - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

NewAmsterdam Pharma Signs Supply Agreement with Menarini - MSN

Aug 16, 2025
pulisher
Aug 16, 2025

Short interest data insights for NewAmsterdam Pharma Company N.V.July 2025 Recap & Free Fast Gain Swing Trade Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

How moving averages guide NewAmsterdam Pharma Company N.V. trading2025 Biggest Moves & Free High Accuracy Swing Entry Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

How to build a dashboard for NewAmsterdam Pharma Company N.V. Equity Warrant stockPortfolio Growth Summary & Free Risk Controlled Daily Trade Plans - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

Can technical indicators confirm NewAmsterdam Pharma Company N.V.’s reversalJuly 2025 Spike Watch & Reliable Price Breakout Alerts - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

NewAmsterdam Pharma Company N.V. Equity Warrant’s Price Action Aligns with Quant SignalsJuly 2025 Spike Watch & Fast Gain Stock Tips - sundaytimes.kr

Aug 15, 2025
pulisher
Aug 15, 2025

What makes NewAmsterdam Pharma Company N.V. stock price move sharply2025 EndofYear Setup & Safe Entry Zone Tips - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Published on: 2025-08-15 19:06:53 - sundaytimes.kr

Aug 15, 2025
pulisher
Aug 15, 2025

How to interpret RSI for NewAmsterdam Pharma Company N.V. Equity Warrant stock2025 Stock Rankings & Community Trade Idea Sharing Platform - Newser

Aug 15, 2025
pulisher
Aug 14, 2025

Live market analysis of NewAmsterdam Pharma Company N.V.July 2025 Trade Ideas & AI Enhanced Execution Alerts - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

NewAmsterdam Pharma Company N.V. Announces Resignation of Michael Davidson as Chief Executive Officer, Effective August 11, 2025 - MarketScreener

Aug 14, 2025
pulisher
Aug 14, 2025

NewAmsterdam Pharma Director Topper James N Buys 471 Shares at $23.98/Share. - AInvest

Aug 14, 2025
pulisher
Aug 13, 2025

New Amsterdam Pharma director Topper buys $11k in shares By Investing.com - Investing.com South Africa

Aug 13, 2025
pulisher
Aug 13, 2025

New Amsterdam Pharma director Topper buys $11k in shares - Investing.com

Aug 13, 2025
pulisher
Aug 12, 2025

Published on: 2025-08-13 00:48:28 - 선데이타임즈

Aug 12, 2025
pulisher
Aug 11, 2025

Analysts Just Made A Massive Upgrade To Their NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Forecasts - 富途牛牛

Aug 11, 2025
pulisher
Aug 11, 2025

Piper Sandler reiterates Overweight rating on NewAmsterdam Pharma stock By Investing.com - Investing.com Nigeria

Aug 11, 2025
pulisher
Aug 11, 2025

Piper Sandler reiterates Overweight rating on NewAmsterdam Pharma stock - Investing.com India

Aug 11, 2025
pulisher
Aug 11, 2025

William Blair Brokers Increase Earnings Estimates for NAMS - Defense World

Aug 11, 2025
pulisher
Aug 11, 2025

Leerink Partnrs Issues Optimistic Outlook for NAMS Earnings - Defense World

Aug 11, 2025
pulisher
Aug 11, 2025

Bullish: Analysts Just Made A Meaningful Upgrade To Their NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Forecasts - Yahoo Finance

Aug 11, 2025
pulisher
Aug 09, 2025

Analysts Are Upgrading NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) After Its Latest Results - Yahoo Finance

Aug 09, 2025
pulisher
Aug 09, 2025

Comparing NewAmsterdam Pharma Company N.V. Equity Warrant in custom built stock radarsFree Trade Setups With Clear Risk Limits - Newser

Aug 09, 2025
pulisher
Aug 08, 2025

Visualizing NewAmsterdam Pharma Company N.V. Equity Warrant stock with heatmapsWeekly Price Target Forecast and Alerts - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Technical analysis overview for NewAmsterdam Pharma Company N.V. stockFree AI Driven Buy Alert Trade Blueprint - Newser

Aug 08, 2025

Newamsterdam Pharma Company Nv Stock (NAMS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Newamsterdam Pharma Company Nv Stock (NAMS) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Kling Douglas F
Chief Operating Officer
Jul 16 '25
Option Exercise
10.90
51,043
556,369
95,043
Kling Douglas F
Chief Operating Officer
Jul 15 '25
Option Exercise
10.90
47,569
518,502
91,569
Kling Douglas F
Chief Operating Officer
Jul 16 '25
Sale
21.10
51,043
1,077,007
44,000
Kling Douglas F
Chief Operating Officer
Jul 15 '25
Sale
21.44
47,569
1,019,648
44,000
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Cap:     |  Volume (24h):